Tamoxifen subcellular localization; Observation of cell-specific cytotoxicity enhancement by inhibition of mitochondrial ETC complexes i and III

Photochemistry and Photobiology

Volumn 88, Issue 4, 2012, Pages 1016-1022

  Theodossiou, Theodossis Athanassios ^a   Yannakopoulou, Konstantina ^a   Aggelidou, Chrysie ^a   Hothersall, John Stephen ^b  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCIN A1; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; ESTROGEN RECEPTOR; METHACRYLIC ACID DERIVATIVE; MYXOTHIAZOL; POLYENE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE; STIGMATELLIN; TAMOXIFEN; THIAZOLE DERIVATIVE; UBIQUINOL CYTOCHROME C REDUCTASE;

ANIMAL; ANTIBODY SPECIFICITY; BREAST TUMOR; CELL SURVIVAL; CONFERENCE PAPER; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENDOPLASMIC RETICULUM; ENZYMOLOGY; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; MALE; METABOLISM; MITOCHONDRION; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ANIMALS; ANTIMYCIN A; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG SYNERGISM; ELECTRON TRANSPORT COMPLEX I; ELECTRON TRANSPORT COMPLEX III; ENDOPLASMIC RETICULUM; FEMALE; HUMANS; MALE; METHACRYLATES; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA; ORGAN SPECIFICITY; POLYENES; PROSTATIC NEOPLASMS; RECEPTORS, ESTROGEN; ROTENONE; TAMOXIFEN; THIAZOLES;

EID: 84863724598     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2012.01144.x     Document Type: Conference Paper

References (46)

1. McKeon, V. A., (1999) The breast cancer prevention trial: should women at risk take tamoxifen? J. Obstet. Gynecol. Neonatal. Nurs. 28, 34-38.
2. Fisher, B., J. P. Costantino, D. L. Wickerham, C. K. Redmond, M. Kavanah, W. M. Cronin, V. Vogel, A. Robidoux, N. Dimitrov, J. Atkins, M. Daly, S. Wieand, E. Tan-Chiu, L. Ford, and, N. Wolmark, (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl Cancer Inst. 90, 1371-1388.
3. Radmacher, M. D., and, R. Simon, (2000) Estimation of tamoxifen's efficacy for preventing the formation and growth of breast tumors. J. Natl Cancer Inst. 92, 48-53.
4. Early Breast Cancer Trialists' Collaborative Group. (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women. Lancet 339, 1-15.
5. Love, R. R., (1989) Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects. J. Clin. Oncol. 7, 803-815.
6. Buckley, M. M., and, K. L. Goa, (1989) Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use. Drugs 37, 451-490.
7. Osborne, C. K., (1998) Steroid hormone receptors in breast cancer management. Breast Cancer Res. Treat. 51, 227-238.
8. Osborne, C. K., (1998) Tamoxifen in the treatment of breast cancer. N. Engl. J. Med. 339, 1609-1618.
9. Diel, P., K. Smolnikar, and, H. Michna, (1999) The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and down regulation of BCL-2 than tamoxifen in MCF-7 cells. Breast Cancer Res. Treat. 58, 87-97.
10. Salami, S., and, F. Karami-Tehrani, (2003) Biochemical studies of apoptosis induced by tamoxifen in estrogen receptor positive and negative breast cancer cell lines. Clin. Biochem. 36, 247-253.
11. Somai, S., M. Chaouat, D. Jacob, J. Y. Perrot, W. Rostene, P. Forgez, and, A. Gompel, (2003) Antiestrogens are pro-apoptotic in normal human breast epithelial cells. Int. J. Cancer 105, 607-612.
12. Kandouz, M., A. Lombet, J. Y. Perrot, D. Jacob, S. Carvajal, A. Kazem, W. Rostene, A. Therwath, and, A. Gompel, (1999) Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells. J. Steroid Biochem. Mol. Biol. 69, 463-471.
13. Ferlini, C., G. Scambia, M. Marone, M. Distefano, C. Gaggini, G. Ferrandina, A. Fattorossi, G. Isola, P. Benedetti Panici, and, S. Mancuso, (1999) Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines. Br. J. Cancer 79, 257-263.
14. 2+ influx in the mechanism of tamoxifen-induced apoptosis in HepG2 human hepatoblastoma cells. Cancer Lett. 147, 115-123.
15. Lehenkari, P., V. Parikka, T. J. Rautiala, M. Weckstrom, J. Dahllund, P. L. Harkonen, and, H. K. Vaananen, (2003) The effects of tamoxifen and toremifene on bone cells involve changes in plasma membrane ion conductance. J. Bone Miner. Res. 18, 473-481.
16. Gelmann, E. P., (1997) Tamoxifen for the treatment of malignancies other than breast and endometrial carcinoma. Semin. Oncol. 24, S1-65-S1-70.
17. Zhang, W., W. T. Couldwell, H. Song, T. Takano, J. H. Lin, and, M. Nedergaard, (2000) Tamoxifen-induced enhancement of calcium signaling in glioma and MCF-7 breast cancer cells. Cancer Res. 60, 5395-5400.
18. Kallio, A., A. Zheng, J. Dahllund, K. M. Heiskanen, and, P. Harkonen, (2005) Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells. Apoptosis 10, 1395-1410.
19. 2+ and inorganic phosphate. Toxicol. Appl. Pharmacol. 152, 10-17.
20. Nazarewicz, R. R., W. J. Zenebe, A. Parihar, S. K. Larson, E. Alidema, J. Choi, and, P. Ghafourifar, (2007) Tamoxifen induces oxidative stress and mitochondrial apoptosis via stimulating mitochondrial nitric oxide synthase. Cancer Res. 67, 1282-1290.
21. Dietze, E. C., L. E. Caldwell, S. L. Grupin, M. Mancini, and, V. L. Seewaldt, (2001) Tamoxifen but not 4-hydroxytamoxifen initiates apoptosis in p53(-) normal human mammary epithelial cells by inducing mitochondrial depolarization. J. Biol. Chem. 276, 5384-5394.
22. Lau, K. M., M. LaSpina, J. Long, and, S. M. Ho, (2000) Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. Cancer Res. 60, 3175-3182.
23. Brooks, S. C., E. R. Locke, and, H. D. Soule, (1973) Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J. Biol. Chem. 248, 6251-6253.
24. Crewe, H. K., L. M. Notley, R. M. Wunsch, M. S. Lennard, and, E. M. Gillam, (2002) Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4'-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen. Drug Metab. Dispos. 30, 869-874.
25. Rickert, E. L., S. Oriana, C. Hartman-Frey, X. Long, T. T. Webb, K. P. Nephew, and, R. V. Weatherman, (2010) Synthesis and characterization of fluorescent 4-hydroxytamoxifen conjugates with unique antiestrogenic properties. Bioconjug. Chem. 21, 903-910.
26. Custodio, J. B., L. M. Almeida, and, V. M. Madeira, (1996) The effect of the anticancer drugs tamoxifen and hydroxytamoxifen on the calcium pump of isolated sarcoplasmic reticulum vesicles. Toxicol. In Vitro 10, 523-531.
27. Thummel, K. E., D. D. Shen, J. G. Hardman, L. E. Limbard, and, A. G. Gilman, (2001) The Pharmacological Basis of Therapeutics. McGraw-Hill, New York.
28. Kisanga, E. R., J. Gjerde, J. Schjott, G. Mellgren, and, E. A. Lien, (2003) Tamoxifen administration and metabolism in nude mice and nude rats. J. Steroid Biochem. Mol. Biol. 84, 361-367.
29. Kisanga, E. R., J. Gjerde, A. Guerrieri-Gonzaga, F. Pigatto, A. Pesci-Feltri, C. Robertson, D. Serrano, G. Pelosi, A. Decensi, and, E. A. Lien, (2004) Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial. Clin. Cancer Res. 10, 2336-2343.
30. Theodossiou, T. A., A. Noronha-Dutra, and, J. S. Hothersall, (2006) Mitochondria are a primary target of hypericin phototoxicity: synergy of intracellular calcium mobilisation in cell killing. Int. J. Biochem. Cell Biol. 38, 1946-1956.
31. von Jagow, G., and, T. A. Link, (1986) Use of specific inhibitors on the mitochondrial bc1 complex. Methods Enzymol. 126, 253-271.
32. Brown, G. C., and, V. Borutaite, (2008) Regulation of apoptosis by the redox state of cytochrome c. Biochim. Biophys. Acta 1777, 877-881.
33. Hancock, J. T., R. Desikan, and, S. J. Neill, (2001) Does the redox status of cytochrome c act as a fail-safe mechanism in the regulation of programmed cell death? Free Radic. Biol. Med. 31, 697-703.
34. Halestrap, A. P., (2009) What is the mitochondrial permeability transition pore? J. Mol. Cell. Cardiol. 46, 821-831.
35. Crompton, M., (1999) The mitochondrial permeability transition pore and its role in cell death. Biochem. J. 341 (Pt 2), 233-249.
36. Tang, D. G., L. Li, D. P. Chopra, and, A. T. Porter, (1998) Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins. Cancer Res. 58, 3466-3479.
37. Wei, M. C., W. X. Zong, E. H. Cheng, T. Lindsten, V. Panoutsakopoulou, A. J. Ross, K. A. Roth, G. R. MacGregor, C. B. Thompson, and, S. J. Korsmeyer, (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292, 727-730.
38. 2+-independent mechanisms that are regulated by Bax. J. Biol. Chem. 276, 19066-19071.
39. Jurgensmeier, J. M., Z. Xie, Q. Deveraux, L. Ellerby, D. Bredesen, and, J. C. Reed, (1998) Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl Acad. Sci. USA 95, 4997-5002.
40. Shimizu, S., M. Narita, and, Y. Tsujimoto, (1999) Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399, 483-487.
41. 2+ ions. J. Cell Biol. 143, 217-224.
42. Custodio, J. B., L. M. Almeida, and, V. M. Madeira, (1993) The active metabolite hydroxytamoxifen of the anticancer drug tamoxifen induces structural changes in membranes. Biochim. Biophys. Acta 1153, 308-314.
43. Custodio, J. B., L. M. Almeida, and, V. M. Madeira, (1993) The anticancer drug tamoxifen induces changes in the physical properties of model and native membranes. Biochim. Biophys. Acta 1150, 123-129.
44. Tuquet, C., J. Dupont, A. Mesneau, and, J. Roussaux, (2000) Effects of tamoxifen on the electron transport chain of isolated rat liver mitochondria. Cell Biol. Toxicol. 16, 207-219.
45. Garrido, C., L. Galluzzi, M. Brunet, P. E. Puig, C. Didelot, and, G. Kroemer, (2006) Mechanisms of cytochrome c release from mitochondria. Cell Death Differ. 13, 1423-1433.
46. Lenaz, G., R. Fato, G. Formiggini, and, M. L. Genova, (2007) The role of coenzyme Q in mitochondrial electron transport. Mitochondrion 7 (Suppl.), S8-S33.